Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients

被引:43
作者
Liu, Fei [1 ]
Gu, Lina [2 ]
Cao, Yu [1 ]
Fan, Xiaojie [2 ]
Zhang, Fengjuan [3 ]
Sang, Meixiang [1 ,2 ]
机构
[1] Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Med Univ, Res Ctr, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
[3] Hebei Med Univ, Ultrasonog Dept, Hosp 4, Shijiazhuang 050017, Hebei, Peoples R China
关键词
histone 3 on lysine 27; prognosis; Enhancer of zeste homology 2; esophageal squamous cell carcinoma; HIGH EXPRESSION; CANCER; PROLIFERATION; METHYLATION; INHIBITION; INVASION; PROTEIN; GENE;
D O I
10.3109/1354750X.2015.1118537
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It has been reported that the trimethylation of histone 3 on lysine 27 (H3K27me3) is required for enhancer of zeste homology 2 (EZH2)-mediated repression of various genes essential for tumorigenesis and tumor development. Here, we reported the expression of EZH2 and H3K27me3 in esophageal squamous cell carcinoma (ESCC) specimens was higher than the pericarcinoma esophageal specimens. Their expression was positively associated with the poor prognosis of ESCC patients. EZH2 expression, histological grade and distant lymph node metastasis were all independent factors for poor prognosis of ESCC. In addition, enforced expression of EZH2 in esophageal cancer-derived cells could increase the overall H3K27me3 level. Our results suggested the expression of EZH2 and H3K27me3 could serve as biomarkers in the prediction of ESCC patients' survival and ESCC metastasis.
引用
收藏
页码:80 / 90
页数:11
相关论文
共 32 条
[1]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2]   Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer [J].
Benard, Anne ;
Goossens-Beumer, Ines J. ;
van Hoesel, Anneke Q. ;
Horati, Hamed ;
Putter, Hein ;
Zeestraten, Eliane C. M. ;
van de Velde, Cornelis J. H. ;
Kuppen, Peter J. K. .
PLOS ONE, 2014, 9 (09)
[3]   Inoperable esophageal cancer and outcome of palliative care [J].
Besharat, Sima ;
Jabbari, Ali ;
Semnani, Shahryar ;
Keshtkar, Abbasali ;
Marjani, Jeran .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (23) :3725-3728
[4]   EZH2 promotes proliferation and invasiveness of prostate cancer cells [J].
Bryant, R. J. ;
Cross, N. A. ;
Eaton, C. L. ;
Hamdy, F. C. ;
Cunliffe, V. T. .
PROSTATE, 2007, 67 (05) :547-556
[5]   H3K27me3 Protein Is a Promising Predictive Biomarker of Patients' Survival and Chemoradioresistance in Human Nasopharyngeal Carcinoma [J].
Cai, Mu-Yan ;
Tong, Zhu-Ting ;
Zhu, Wei ;
Wen, Zhu-Zhi ;
Rao, Hui-Lan ;
Kong, Ling-Ling ;
Guan, Xin-Yuan ;
Kung, Hsiang-Fu ;
Zeng, Yi-Xin ;
Xie, Dan .
MOLECULAR MEDICINE, 2011, 17 (11-12) :1137-1145
[6]   High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients [J].
Cai, Mu-Yan ;
Hou, Jing-Hui ;
Rao, Hui-Lan ;
Luo, Rong-Zhen ;
Li, Mei ;
Pei, Xiao-Qing ;
Lin, Marie C. ;
Guan, Xin-Yuan ;
Kung, Hsiang-Fu ;
Zeng, Yi-Xin ;
Xie, Dan .
MOLECULAR MEDICINE, 2011, 17 (1-2) :12-20
[7]   Role of histone H3 lysine 27 methylation in polycomb-group silencing [J].
Cao, R ;
Wang, LJ ;
Wang, HB ;
Xia, L ;
Erdjument-Bromage, H ;
Tempst, P ;
Jones, RS ;
Zhang, Y .
SCIENCE, 2002, 298 (5595) :1039-1043
[8]   The human EZH2 gene:: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders [J].
Cardoso, C ;
Mignon, C ;
Hetet, G ;
Grandchamps, B ;
Fontes, M ;
Colleaux, L .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (03) :174-180
[9]  
Crea Francesco, 2011, Epigenomics, V3, P12
[10]   EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer [J].
Debeb, Bisrat G. ;
Gong, Yun ;
Atkinson, Rachel L. ;
Sneige, Nour ;
Huo, Lei ;
Gonzalez-Angulo, Ana Maria ;
Hung, Mien-Chie ;
Valero, Vicente ;
Ueno, Naoto T. ;
Woodward, Wendy A. .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33